Gao M, Wu Y, Zhang L, Zhou Y, Liu H, Zhang W
Sci Rep. 2025; 15(1):8857.
PMID: 40087295
DOI: 10.1038/s41598-025-92925-6.
Chen T, Liu G, Chen S, Zhang F, Ma S, Bai Y
Acta Pharm Sin B. 2025; 15(1):467-483.
PMID: 40041899
PMC: 11873566.
DOI: 10.1016/j.apsb.2024.07.013.
Cao M, Yan J, Ding Y, Zhang Y, Sun Y, Jiang G
Cell Death Dis. 2025; 16(1):148.
PMID: 40032844
PMC: 11876696.
DOI: 10.1038/s41419-025-07458-7.
Chen X, Yuan Y, Zhou F, Li L, Pu J, Jiang X
J Transl Med. 2025; 23(1):245.
PMID: 40022120
PMC: 11871626.
DOI: 10.1186/s12967-025-06221-y.
Zhang H, Lu W, Tang H, Chen A, Gao X, Zhu C
Medicina (Kaunas). 2025; 61(2).
PMID: 40005339
PMC: 11857502.
DOI: 10.3390/medicina61020222.
De novo basecalling of RNA modifications at single molecule and nucleotide resolution.
Cruciani S, Delgado-Tejedor A, Pryszcz L, Medina R, Llovera L, Novoa E
Genome Biol. 2025; 26(1):38.
PMID: 40001217
PMC: 11853310.
DOI: 10.1186/s13059-025-03498-6.
The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes.
Shi T, Zhang H, Chen Y
Cell Biosci. 2025; 15(1):27.
PMID: 39987091
PMC: 11846233.
DOI: 10.1186/s13578-025-01368-z.
The role of N(6)-methyladenosine (m6a) modification in cancer: recent advances and future directions.
Xie X, Fang Z, Zhang H, Wang Z, Li J, Jia Y
EXCLI J. 2025; 24:113-150.
PMID: 39967906
PMC: 11830918.
DOI: 10.17179/excli2024-7935.
Interplay of m6A RNA methylation and gut microbiota in modulating gut injury.
Wang H, Han J, Zhang X
Gut Microbes. 2025; 17(1):2467213.
PMID: 39960310
PMC: 11834532.
DOI: 10.1080/19490976.2025.2467213.
Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications.
Li P, Fang X, Huang D
Eur J Med Res. 2025; 30(1):98.
PMID: 39940056
PMC: 11823136.
DOI: 10.1186/s40001-025-02353-5.
Epigenetic regulation in female reproduction: the impact of m6A on maternal-fetal health.
Li P, Lin Y, Ma H, Zhang J, Zhang Q, Yan R
Cell Death Discov. 2025; 11(1):43.
PMID: 39904996
PMC: 11794895.
DOI: 10.1038/s41420-025-02324-z.
mA modification: a new avenue for anti-cancer therapy.
Bai Y, Li K, Peng J, Yi C
Life Med. 2025; 2(1):lnad008.
PMID: 39872957
PMC: 11749794.
DOI: 10.1093/lifemedi/lnad008.
The role of N-methyladenosine (mA) mRNA modifications in herpesvirus infections.
Verhamme R, Favoreel H
J Virol. 2025; 99(2):e0172324.
PMID: 39868828
PMC: 11852997.
DOI: 10.1128/jvi.01723-24.
Research progress on N6-methyladenosine RNA modification in osteosarcoma: functions, mechanisms, and potential clinical applications.
Yang Y, Ni W, Yang Y, Liao J, Yang Y, Li J
Med Oncol. 2025; 42(3):55.
PMID: 39853585
DOI: 10.1007/s12032-024-02597-x.
Unlocking the potential for optic nerve regeneration over long distances: a multi-therapeutic intervention.
Liu Z, Zhou L, Sun Y, Ma Y, Liu C, Zhang B
Front Neurol. 2025; 15():1526973.
PMID: 39850731
PMC: 11754882.
DOI: 10.3389/fneur.2024.1526973.
Decoding the mA epitranscriptomic landscape for biotechnological applications using a direct RNA sequencing approach.
Liu C, Liang H, Wan A, Xiao M, Sun L, Yu Y
Nat Commun. 2025; 16(1):798.
PMID: 39824841
PMC: 11742432.
DOI: 10.1038/s41467-025-56173-6.
WTAP knockdown inhibits cell migration through regulating SNAIL1 expression in colorectal cancer.
Han J, Zhang J, Shi H, Wen X
Am J Transl Res. 2025; 16(12):8023-8031.
PMID: 39822563
PMC: 11733317.
DOI: 10.62347/QAQE4354.
Epigenetic Mechanisms in Osteoporosis: Exploring the Power of mA RNA Modification.
Tian S, Song Y, Guo L, Zhao H, Bai M, Miao M
J Cell Mol Med. 2025; 29(1):e70344.
PMID: 39779466
PMC: 11710941.
DOI: 10.1111/jcmm.70344.
hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression.
Jin G, Song Y, Fang S, Yan M, Yang Z, Shao Y
J Exp Clin Cancer Res. 2025; 44(1):8.
PMID: 39773744
PMC: 11705778.
DOI: 10.1186/s13046-024-03264-9.
DUX4-induced HSATII RNA accumulation drives protein aggregation impacting RNA processing pathways.
Arends T, Bennett S, Tapscott S
bioRxiv. 2025; .
PMID: 39764024
PMC: 11702838.
DOI: 10.1101/2024.12.17.628988.